Aerpio Pharmaceuticals, Inc. Financial Statements 2011-2024 | ARPO

Annual Financial Statements Aerpio Pharmaceuticals, Inc.

	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	63.6 M	26.4 M	132 M	108 M	-	-	-	-	-	-
Shares	42.1 M	40.6 M	33.9 M	21.7 M	-	-	-	-	-	-
Net Income	-4.32 M	-23.3 M	-10.4 M	-21.4 M	-39.4 K	-31.4 K	-28.7 K	-27.4 K	-27.2 K	-22.4 K
Revenue	15 M	-	20.2 M	-	-	-	-	-	-	-
EBITDA	-6.22 M	-22.4 M	-11.1 M	-21.3 M	-29.5 K	-23 K	-22.8 K	-22.4 K	-23.6 K	-20.5 K
Operating Expenses	21.3 M	22.4 M	31.3 M	21.4 M	29.5 K	23 K	22.8 K	22.4 K	23.6 K	20.5 K
General and Administrative Expenses	8.76 M	9.76 M	13.5 M	9.24 M	29.5 K	23 K	22.8 K	22.4 K	23.6 K	20.5 K

All numbers in USD currency